secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiff Oncology, Inc. (CRDF)
CIK:        0001213037
Form:       8-K
Filed at:   2026-07-16T12:38:12+00:00
Accession:  0001193125-26-305467
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardiff Oncology raises ~$10M in registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Sold 8,571,429 shares at $1.05/share with warrants for 8,571,429 shares at $1.31 exercise price.
- Insiders purchased 731,707 shares at $1.435/share with warrants; total gross proceeds ~$10M.
- Warrants exercisable after six months and authorized share increase; expire 5.5 years from start.
- Net proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent; closing expected July 16, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213037/000119312526305467/0001193125-26-305467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213037/000119312526305467/crdf-20260714.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-305467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer